Equities

Premier Health of America Inc

PHA:CVE

Premier Health of America Inc

Actions
  • Price (CAD)0.14
  • Today's Change0.005 / 3.70%
  • Shares traded26.50k
  • 1 Year change-62.67%
  • Beta0.6031
Data delayed at least 15 minutes, as of Sep 20 2024 20:47 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CAD
(except for per share items)
Fiscal data as of Sep 30 2023202320222021
ASSETS
Cash And Short Term Investments1.155.122.68
Total Receivables, Net242012
Total Inventory------
Prepaid expenses0.610.280.33
Other current assets, total------
Total current assets262515
Property, plant & equipment, net6.644.184.68
Goodwill, net141510
Intangibles, net10129.60
Long term investments------
Note receivable - long term00.250.20
Other long term assets0.010.010.01
Total assets575739
LIABILITIES
Accounts payable3.691.871.08
Accrued expenses4.974.563.73
Notes payable/short-term debt00.060
Current portion long-term debt/capital leases0.860.900.67
Other current liabilities, total1.785.171.13
Total current liabilities11136.62
Total long term debt262212
Total debt272312
Deferred income tax2.263.102.48
Minority interest------
Other liabilities, total0.311.081.08
Total liabilities403922
SHAREHOLDERS EQUITY
Common stock141413
Additional paid-in capital0.450.090.02
Retained earnings (accumulated deficit)1.713.973.81
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity161817
Total liabilities & shareholders' equity575739
Total common shares outstanding555654
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.